Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease

Circulation. 1989 Oct;80(4):749-56. doi: 10.1161/01.cir.80.4.749.
No abstract available

Publication types

  • Review

MeSH terms

  • Aspirin / adverse effects
  • Aspirin / therapeutic use*
  • Biomechanical Phenomena
  • Cardiovascular Diseases / prevention & control*
  • Gastrointestinal Diseases / chemically induced
  • Humans
  • Myocardial Infarction / prevention & control
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Recurrence
  • Risk Factors

Substances

  • Platelet Aggregation Inhibitors
  • Aspirin